Image de couverture de livre

Redefining phenotypic intratumor heterogeneity of pancreatic ductal adenocarcinoma: a bottom‐up approach

Fuente: Wiley Open Access

Enregistré dans:

Détails bibliographiques
Auteurs principaux:	Marc Hilmi, Flore Delecourt, Jérôme Raffenne, Taib Bourega, Nelson Dusetti, Juan Iovanna, Yuna Blum, Magali Richard, Cindy Neuzillet, Anne Couvelard, Matthieu Tihy, Louis de Mestier, Vinciane Rebours, Rémy Nicolle, Jérôme Cros
Format:	Artículo Open Access
Publié:	Wiley 2025
Sujets:	The Journal of Pathology
Accès en ligne:	Acceder al recurso
Tags:	Ajouter un tag Pas de tags, Soyez le premier à ajouter un tag!

Documents similaires

Toward Precision Chemotherapy for Pancreatic Cancer Guided by Transcriptomic Signatures
par: Brice Chanez, et autres
Publié: (2025)

Molecular characteristics of early‐onset pancreatic ductal adenocarcinoma
par: Silvana Debernardi, et autres
Publié: (2024)

Kinase activities in pancreatic ductal adenocarcinoma with prognostic and therapeutic avenues
par: Andrea Vallés‐Martí, et autres
Publié: (2024)

Spatial heterogeneity of antibody–drug conjugate targets in pancreatic ductal adenocarcinoma
par: Deema Sabtan, et autres
Publié: (2026)

Molecular classification and intratumoral heterogeneity of gastric adenocarcinoma
par: Takeshi Kuwata
Publié: (2024)

Differentiating localized autoimmune pancreatitis and pancreatic ductal adenocarcinoma using endoscopic ultrasound images with deep learning
par: Hitomi Nakamura, et autres
Publié: (2024)

Identification of serum protein biomarkers for pre‐cancerous lesions associated with pancreatic ductal adenocarcinoma
par: Hannah Mearns, et autres
Publié: (2026)

ARP2/3 complex affects myofibroblast differentiation and migration in pancreatic ductal adenocarcinoma
par: Yifeng Sun, et autres
Publié: (2024)

Risk factors for suicide in patients with pancreatic ductal adenocarcinoma: A population‐based study
par: Chao Wang, et autres
Publié: (2024)

Deciphering transcriptional plasticity in pancreatic ductal adenocarcinoma reveals alterations in sensory neuron innervation
par: Elena Genova, et autres
Publié: (2026)

Concurrent targeting of GSK3 and MEK as a therapeutic strategy to treat pancreatic ductal adenocarcinoma
par: Junki Fukuda, et autres
Publié: (2024)

Real‐world genome profiling in Japanese patients with pancreatic ductal adenocarcinoma focusing on HRD implications
par: Toshifumi Doi, et autres
Publié: (2024)

Association between prediagnostic serum metabolites and pancreatic ductal adenocarcinoma risk in two prospective cohorts
par: Ting Zhang, et autres
Publié: (2025)

Novel machine‐learning model for predicting lymph node metastasis in resectable pancreatic ductal adenocarcinoma
par: Susumu Daibo, et autres
Publié: (2024)

Peptidase inhibitor 16 promotes proliferation of pancreatic ductal adenocarcinoma cells through OASL signaling
par: Qun Chen, et autres
Publié: (2024)

YAP‐LAMB3 axis dictates cellular resistance of pancreatic ductal adenocarcinoma cells to gemcitabine
par: Yecheng Li, et autres
Publié: (2024)

Rotational migration in human pancreatic ductal organoids depends on actin and myosin activity
par: Xie, Gengqiang, et autres
Publié: (2025)

Stroma gene signature predicts responsiveness to chemotherapy in pancreatic ductal adenocarcinoma patient‐derived xenograft models
par: Alessia Anastasia, et autres
Publié: (2025)

The impact of the California state lockdown during the COVID‐19 pandemic on management of patients with pancreatic ductal adenocarcinoma
par: Parisa Oviedo, et autres
Publié: (2024)

Plasma cell‐free DNA markers predict occult metastases in patients with resectable pancreatic ductal adenocarcinoma
par: Jacob E. Till, et autres
Publié: (2026)

Hexokinase 2 nonmetabolic function‐mediated phosphorylation of IκBα enhances pancreatic ductal adenocarcinoma progression
par: Yingying Tong, et autres
Publié: (2024)

Minimally invasive determination of pancreatic ductal adenocarcinoma ( PDAC ) subtype by means of circulating cell‐free RNA
par: Martin Metzenmacher, et autres
Publié: (2024)

The inverted U‐shaped relationship between epinephrine and pancreatic ductal adenocarcinoma patients' survival with compensation of lymphocyte
par: Bing‐Xue Li, et autres
Publié: (2024)

Evaluation of fine‐needle core biopsy specimens for pancreatic ductal adenocarcinoma: Diagnostic utility and helpful histological features
par: Raul S Gonzalez, et autres
Publié: (2024)

Inhibition of PHF1 promotes ferroptosis via IRES‐dependent Snail translation regulation in pancreatic ductal adenocarcinoma
par: Yujiao Xie, et autres
Publié: (2026)

Targeting iron–sulfur cluster assembly scaffold protein as a vulnerability in KRAS‐activated pancreatic ductal adenocarcinoma
par: Huarui Cai, et autres
Publié: (2024)

Mutant p53 affects the mitochondrial proteome, promoting mitochondrial fragmentation and OXPHOS in pancreatic ductal adenocarcinoma cells
par: Maria Poles, et autres
Publié: (2025)

Integration of dual‐energy CT characteristics and biomarkers: Noninvasive prediction of Ki‐67 expression in pancreatic ductal adenocarcinoma
par: Wuyang Zhang, et autres
Publié: (2026)

Diagnostic utility of p53, SMAD4, and the novel biomarker PON2 in FNA of pancreatic ductal adenocarcinoma
par: Ruimeng Yang, et autres
Publié: (2025)

A large language model for predicting pancreatic ductal adenocarcinoma patients from blood-derived exosomal transcriptomics data
par: Choudhury, Shubham, et autres
Publié: (2026)

Technical recommendation on multiplex MR elastography for tomographic mapping of abdominal stiffness with a focus on the pancreas and pancreatic ductal adenocarcinoma
par: Schattenfroh, Jakob, et autres
Publié: (2025)

Nrf2‐mediated adenylosuccinate lyase promotes resistance to gemcitabine in pancreatic ductal adenocarcinoma cells through ferroptosis escape
par: Tung‐Wei Hsu, et autres
Publié: (2024)

Response to “The role of adjuvant chemotherapy in management of stage I pancreatic ductal adenocarcinoma deserves independent high quality research”
par: Wooil Kwon, et autres
Publié: (2024)

Circulating cell‐free DNA methylation‐based multi‐omics analysis allows early diagnosis of pancreatic ductal adenocarcinoma
par: Guochao Zhao, et autres
Publié: (2024)

In Response to Accuracy and Clinical Findings of Saliva Digestive Biomarkers in Laryngopharyngeal Reflux Disease
par: Jerome R. Lechien, et autres
Publié: (2026)

Single‐cell RNA sequencing and high‐dimensional flow cytometry reveal distinct peripheral immune landscapes of type 1 autoimmune pancreatitis and pancreatic ductal adenocarcinoma
par: Chenxiao Liu, et autres
Publié: (2026)

Development of irreversible pancreatic ductal change triggered by pancreatic duct stenting in chronic pancreatitis
par: Kensuke Takuma, et autres
Publié: (2024)

Anti‐tumorigenic effects of naive and TLR4‐primed adipose‐derived mesenchymal stem cells on pancreatic ductal adenocarcinoma cells
par: Demet Kaçaroğlu, et autres
Publié: (2024)

Serum matrix metalloproteinase‐7, Syndecan‐1, and CA 19‐9 as a biomarker panel for diagnosis of pancreatic ductal adenocarcinoma
par: Doron Yablecovitch, et autres
Publié: (2024)

Jorunnamycin A induces apoptosis in pancreatic ductal adenocarcinoma cells, spheroids, and patient-derived organoids by modulating KRAS-mediated survival pathways.
par: Khine, Hnin Ei Ei, et autres
Publié: (2025)